Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2021
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
0
Like
Facebook
Tweet this
Print
Wei Gao, PhD
Merck & Co., Inc.
Disclosure:
Merck & Co., Inc.
(Employee, Shareholder)
Poster(s):
523 - Use of Immune-Viral Dynamics Modeling to Understand Molnupiravir Drug Effect for COVID-19
543 - Molnupiravir maintains antiviral activity against SARS-CoV-2 variants in vitro and in early clinical studies
998 - Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654
1013 - Predicting RSV Efficacy for MK-1654 in Temperate and Tropical Climates using MBMA and Clinical Trial Simulation to Account for Seasonal Differences in RSV Force-of-Infection
